3-D MatrixDMTRF 55 Gross Margin % is 78.65% as of Jan. 2026, which is 58% above its 10-year median of 49.78. GuruFocus rates DMTRF with a GF Score™ of 55/100 and a GF Value™ of $2.15 (Fairly Valued). The stock has 3 warning signs investors should review. Among 805 Medical Devices & Instruments companies, 3-D Matrix ranks better than 90.68% on this metric.
Gross Margin % is calculated as gross profit divided by its revenue. 3-D Matrix's Gross Profit for the
three
months ended in Jan. 2026 was $12.75 Mil. 3-D Matrix's Revenue for the
three
months ended in Jan. 2026 was $16.21 Mil. Therefore, 3-D Matrix's Gross Margin % for the quarter that ended in Jan. 2026 was 78.65%.
The historical rank and industry rank for 3-D Matrix's Gross Margin % or its related term are showing as below:
DMTRF'
s Gross Margin % Range Over the Past 10 Years
Min: 5.08 Med: 49.78 Max: 83.51
Current: 78.74
During the past 13 years, the highestGross Margin % of 3-D Matrix was 83.51%. The lowest was 5.08%. And the median was 49.78%.
DMTRF's Gross Margin % is ranked better than 90.68% of 805
companies
in the Medical Devices & Instruments industry
Industry Median: 52.07
vs DMTRF: 78.74
3-D Matrix had a gross margin of 78.65% for the quarter that ended in Jan. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for 3-D Matrix was 19.30% per year.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
3-D Matrix had a gross margin of 78.65% for the quarter that ended in Jan. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
3-D Matrix Gross Margin % Related Terms
3-D Matrix Gross Margin % Historical Data
* Premium members only.
The historical data trend for 3-D Matrix's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, 3-D Matrix's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
3-D Matrix Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, 3-D Matrix's Gross Margin % distribution charts can be found below:
* The bar in red indicates where 3-D Matrix's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
3-D Matrix (DMTRF) has a Gross Margin % of 78.65% as of Jan. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on 3-D Matrix and its competitors. This is 58% above median its historical median of 49.78. Over the past decade, 3-D Matrix's Gross Margin % has ranged from 5.08 to 83.51. According to the industry distribution chart, 3-D Matrix ranks #75 out of 805 companies in the Medical Devices & Instruments industry, placing it in the top 9.3%.
Is 3-D Matrix's Gross Margin % too high?
3-D Matrix's current Gross Margin % of 78.65% is 58% above median its 10-year median of 49.78. Over the past 10 years, this metric has ranged from a low of 5.08 to a high of 83.51. The Medical Devices & Instruments industry median Gross Margin % is 52.07. 3-D Matrix's value of 78.65% is 51% above this industry median. Based on the distribution chart, 3-D Matrix ranks #75 out of 805 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, 3-D Matrix has a GF Score™ of 55/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does 3-D Matrix's Gross Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, 3-D Matrix ranks #75 out of 805 companies for Gross Margin %. This places 3-D Matrix in the top 9% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 52.07. 3-D Matrix's value of 78.65% is 51% above this benchmark. Historically, 3-D Matrix's own Gross Margin % has ranged from 5.08 to 83.51 over the past decade. While the company's 10-year median is 49.78 vs. the industry median of 52.07, 3-D Matrix has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.07, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. 3-D Matrix's current Gross Margin % of 78.65% is 51% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on 3-D Matrix and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. 3-D Matrix's current Gross Margin % is 78.65%, which is 58% above median its own 10-year median of 49.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 3-D Matrix stock overvalued right now?
Based on GuruFocus' analysis, 3-D Matrix (DMTRF) is currently considered Fairly Valued. The stock's GF Value™ is $2.15, compared to a current price of $2.25 — trading 4.7% above its estimated fair value. The current Gross Margin % is 78.65%, which is 58% above median its 10-year median of 49.78 and 51% above the Medical Devices & Instruments industry median of 52.07. 3-D Matrix's overall GF Score™ is 55/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For 3-D Matrix (DMTRF), the current Gross Margin % is 78.65% as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is 3-D Matrix (DMTRF) Overvalued in 2026?
Based on GuruFocus' analysis, 3-D Matrix stock appears to be overvalued.
The current stock price of $2.25 is trading 4.7% above its estimated GF Value™ of $2.15.
GuruFocus considers 3-D Matrix to be Fairly Valued.
Key valuation signals for DMTRF:
Gross Margin %: 78.65% (58% above median its 10-year median of 49.78)
GF Value™: $2.15 vs. price of $2.25 (4.7% above fair value)
Industry Position: 51% above the Medical Devices & Instruments median (#75 of 805)
No single metric tells the full story. See the DMTRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
3-D Matrix Ltd is engaged in the research, development, manufacture, and sale of medical devices based on the self-assembling peptide technology. Its products include PuraMatrix, High Concentration PuraMatrix, Modified Peptide and GMP Grade PuraMatrix.
55GF Score
Get the complete analysis for DMTRF
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DMTRF has been successfully added to your 
